Suva LJ - Search Results

1

PTHrP(12-48) Modulates the Bone Marrow Microenvironment and Suppresses Human Osteoclast Differentiation and Lifespan.

Kamalakar A, Washam CL, Akel NS, Allen BJ, Williams DK, Swain FL, Leitzel K, Lipton A, Gaddy D, Suva LJ. Kamalakar A, et al. Among authors: suva lj. J Bone Miner Res. 2017 Jul;32(7):1421-1431. doi: 10.1002/jbmr.3142. Epub 2017 Apr 19. J Bone Miner Res. 2017. PMID: 28370412 Free PMC article.

2

Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.

Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ. Bendre MS, et al. Among authors: suva lj. Cancer Res. 2002 Oct 1;62(19):5571-9. Cancer Res. 2002. PMID: 12359770

3

Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.

Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Bendre MS, et al. Among authors: suva lj. Bone. 2003 Jul;33(1):28-37. doi: 10.1016/s8756-3282(03)00086-3. Bone. 2003. PMID: 12919697

4

Bone is a target for the antidiabetic compound rosiglitazone.

Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B. Rzonca SO, et al. Among authors: suva lj. Endocrinology. 2004 Jan;145(1):401-6. doi: 10.1210/en.2003-0746. Epub 2003 Sep 18. Endocrinology. 2004. PMID: 14500573 Free PMC article.

5

Breast cancer metastasis to bone: it is not all about PTHrP.

Bendre M, Gaddy D, Nicholas RW, Suva LJ. Bendre M, et al. Among authors: suva lj. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S39-45. doi: 10.1097/01.blo.0000093844.72468.f4. Clin Orthop Relat Res. 2003. PMID: 14600591 Review.

6

Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.

Kelly T, Suva LJ, Huang Y, Macleod V, Miao HQ, Walker RC, Sanderson RD. Kelly T, et al. Among authors: suva lj. Cancer Res. 2005 Jul 1;65(13):5778-84. doi: 10.1158/0008-5472.CAN-05-0749. Cancer Res. 2005. PMID: 15994953

7

Regulation of bone mass by mechanical loading: microarchitecture and genetics.

Suva LJ, Gaddy D, Perrien DS, Thomas RL, Findlay DM. Suva LJ, et al. Curr Osteoporos Rep. 2005 Jun;3(2):46-51. doi: 10.1007/s11914-005-0003-0. Curr Osteoporos Rep. 2005. PMID: 16036101 Review.

8

Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.

Lazarenko OP, Rzonca SO, Suva LJ, Lecka-Czernik B. Lazarenko OP, et al. Among authors: suva lj. Bone. 2006 Jan;38(1):74-84. doi: 10.1016/j.bone.2005.07.008. Epub 2005 Aug 30. Bone. 2006. PMID: 16137931 Free PMC article.

9

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.

Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ. Bendre MS, et al. Among authors: suva lj. Cancer Res. 2005 Dec 1;65(23):11001-9. doi: 10.1158/0008-5472.CAN-05-2630. Cancer Res. 2005. PMID: 16322249

10

Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.

Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S, Gaddy D. Perrien DS, et al. Among authors: suva lj. J Clin Endocrinol Metab. 2006 May;91(5):1848-54. doi: 10.1210/jc.2005-2423. Epub 2006 Jan 31. J Clin Endocrinol Metab. 2006. PMID: 16449331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page